Hypoalbuminemia - An Indicator of the Severity and Prognosis of COVID-19 Patients: A Multicentre Retrospective Analysis.

Chaoyue Chen Ying Zhang Xi Zhao Meihui Tao Wei Yan Yu Fu

Published in: Infection and drug resistance (2021)

COVID-19 patients with hypoalbuminemia tend to have more severe clinical manifestations and more abnormal biochemical tests, which may result in poorer clinical outcomes. Nutritional support therapy may improve the clinical outcome of these patients.

Keyphrases

sars cov
end stage renal disease
coronavirus disease
ejection fraction
chronic kidney disease
newly diagnosed
clinical trial
early onset
cross sectional
mesenchymal stem cells
bone marrow
cell therapy